|
Product Life Cycle Management Seminar
Monday, September 10–Tuesday, September 11, 2012
The Ballantyne Hotel & Lodge
Charlotte, N.C.
Seminar Overview
In a managed markets environment, stakeholders work together to streamline the commercial life cycle of pharmaceutical products to maximize sales and efficiency and avoid costly disruptions. Communication is crucial among trading partners to understanding how products are managed across the supply chain. Engage in a practical discussion of key life cycle considerations, including how to leverage data to streamline product flow, manage NDC changes, loss of exclusivity and other market disruptions. Discuss the inventory forecasting required for generic launches and the related demand planning and logistics requirements. Learn from your peers as you participate in roundtable discussions on a variety of industry topics to explore key issues, obstacles and potential solutions.
Target Audience
This industry forum is designed especially for supply chain professionals responsible for:
• Trade, sales, sales operations;
• Vendor relations;
• Channel management, commercial strategy;
• Managed markets;
• Customer service, operations;
• Supply chain and distribution;
• Reverse logistics;
• Commercial operations; and
• Product management, development and marketing.
Sponsors
Preliminary Program Agenda
As of August 17, 2012
| 3:30 PM–4:00 PM |
Seminar Registration |
| 4:00 PM–4:05 PM |
Welcome and Seminar Overview
Perry Fri, Senior Vice President, Industry Relations, Membership & Education, HDMA |
| 4:05 PM–4:30 PM |
Navigating Government and Regulatory Complexities in the Healthcare
Supply Chain
Hear how HDMA is addressing the latest legislative and regulatory priorities at DEA and FDA, on Capitol Hill, as well as in the states. Whether the goal is combating drug diversion, addressing drug shortages, simplifying reimbursement metrics or enhancing patient safety, there are a myriad of efforts underway that bring new levels of regulatory attention to manufacturers and distributors that affect the marketing and distribution of pharmaceutical products.
Speaker: Patrick Kelly, Senior Vice President, Government Affairs, HDMA |
| 4:30 PM–5:15 PM |
Outlook on Specialty and Biotechnology Products
All eyes are on emerging trends in the specialty and biotechnology market, from pipeline activity to shifting distribution models. Join this discussion about a product class that holds great promise in therapeutics as well as evolving go-to-market strategies.
Speaker: Heather Morel, Vice President & General Manager, Reimbursement, Access & Safety Services|AccessMED, McKesson Specialty Health |
| 5:15 PM–6:00 PM |
Product Availability Communications in the Supply Chain
With evolving market dynamics, there is increasing focus on inventory forecasting and demand planning between trading partners. Whether a backorder or product hold is initiated due to a shortage or other market disruption, effective and efficient communication is critical. This session highlights two industry efforts designed to improve communications in the healthcare supply chain. First, hear about the updated "HDMA White Paper on Product Availability: Communication Guidelines for Managing Product Shortages," which focuses on the opportunities for manufacturers and distributors. Next, learn more about the GPhA Accelerated Recovery Initiative (ARI), which is predicated on voluntary communication between the FDA, IMS and stakeholders involved in the manufacturing and distribution of critical generic medications currently in shortage.
Speakers: Michael L. Barnes, PhD, Senior Principal, Sales Analytics and Services U.S., IMS Health, Inc.
Perry Fri, Senior Vice President, Industry Relations, Membership & Education, HDMA |
| 6:00 PM–7:00 PM |
Networking Reception |
| 7:00 PM |
Open Evening |
| |
7:30 AM–8:30 AM |
Continental Breakfast |
8:30 AM–9:30 AM |
Customer Perspectives on Product Introductions
Although execution at retail can make a difference for a successful product launch, a myriad of upstream factors contribute to a launch strategy and its overall success. Hear from downstream customers and key stakeholders in the discussion who will discuss a range of issues impacting a product introduction, from sales force support to formulary determination to inventory planning. This discussion will cover factors that contribute to successful launches and explore supply chain activities relevant for all trading partners.
Panelists: Dave Edwards, Vice President Contract Uptake and Supplier Relations, Premier, Inc.
Sandra K.B. Kinsey, MBA, RPh, Vice President, Pharmacy Merchandising, Wal-Mart Stores, Inc.
Everett Neville, Vice President, Chief Trade Relations Officer, Express Scripts |
9:30 AM–10:30 AM |
Practical Tips for Successfully Managing SKU Product Changes or NDC Transitions
Large-scale shifts in the competitive landscape have escalated the importance of successful product launches and have increased demand volatility and SKU proliferation. All of these conditions require strong planning capabilities to properly navigate these shifts. This presentation will outline practical steps to consider for successfully managing SKU product changes or NDC transitions from business process planning, inventory planning and forecasting, internal and external communications with trading partners and more. Learn how to identify and overcome potential pitfalls and obstacles as the speakers lead an interactive discussion.
Speakers: Kathy Marie Blecha, National Account Director, Actient Pharmaceuticals LLC
Michael G. Ladewski, Associate Director, Trade & Distribution, Amylin Pharmaceuticals, LLC |
10:30 AM-11:00 AM |
Networking Break and Table-Top Exhibits |
11:00 AM–12:00 PM |
Loss of Exclusivity: An Inventory Management Case Study
The "patent cliff" has arrived, with many high-volume brands beginning to face generic competition. Whenever a brand loses exclusivity, the organization works to manage expectations between demand forecasts and actual inventory to diminish the impact of returns and accurately predict the financial implications. This presentation will discuss the impact that Loss of Exclusivity (LOE) events have on future return volume and hear the status and key findings of the HDMA Project: LOE ‐ An Inventory Management Case Study.
Speakers: Edward Crimmins, Partner, Kindler & Crimmins Associates
Stephen Kindler, Partner, Kindler & Crimmins Associates |
12:00 PM–1:00 PM |
Networking Luncheon and Table-Top Exhibits |
1:00 PM–2:15 PM |
Roundtable Discussions
Roundtable discussions provide an opportunity to learn in small groups through peer discussion of key issues, obstacles and potential solutions. Attendees will rotate once, which will provide an opportunity to participate in two topic discussions. Be ready to identify if there are “successes” or “goal states.” This will help drive greater awareness and action to share during the “Report Back — Lightning Round” discussion.
Topics and Facilitators:
- GPO Economic Outlook and Perspectives on Cost Drivers and Inflationary Data
Kayla Sutton, Managing Director, Economic Outlook, Premier, Inc.
- Managing SKU Product Changes or NDC Transitions
Kathy Marie Blecha, National Account Director, Actient Pharmaceuticals LLC; and Michael G. Ladewski, Associate Director, Trade & Distribution, Amylin Pharmaceuticals, LLC
- Hot Topics Selected by the Attendees (2-3)
Potential topics include: New Product Introduction Form; Returns; Product Launch Issues; Data Sharing; Managing a Brand Down
|
2:15 PM–3:15 PM |
Embracing Data-Driven Decision Making
As the volume of available channel data grows, trading partners are navigating through new waters in accessing, sharing and understanding inventory movement and forecasting accuracy. Manufacturers envision greater support for product life cycle plans and maximizing marketing efforts, while all parties see value in streamlining supply chain operations. Also, hear how market insights are evolving to support product launches with channel data linked from the pharmacy level and join the discussion about transparency, trust and timeliness in the context of data- driven decision making.
Speaker: Jeff Borman, Vice President of Advanced Analytics, IntegriChain, Inc. |
3:15 PM–3:30 PM |
Recap and Looking Forward
The seminar concludes with an open discussion on the insights gained from the program and potential forward-looking actions to continue to foster conversation around solutions to complex product life cycle management challenges and opportunities. |
4:00 PM |
Adjournment |
*Agenda subject to change.
|
